Regenix Drugs Ltd & Dr. A. Ramamurthy Shine at India’s Healthcare “Oscars” – Healthcare Super Brand Awards 2026
In a resounding recognition of innovation and global impact, Regenix Drugs Ltd and its visionary founder, Dr. A. Ramamurthy, Chairman & Managing Director of the Regenix Group, emerged as the undisputed stars of the 17th Annual Healthcare Leadership Summit & Awards 2026, held at the Hotel Mumbai International Airport.
At this landmark gathering — universally hailed as the “Oscars of Indian Healthcare” — Regenix Drugs Ltd was honored as the “Most Admired Global Pharmaceutical Manufacturer: Leadership in Innovation & Quality 2026,” while Dr. Ramamurthy himself was celebrated as the “Most Innovative & Promising Healthcare Leader in Biosimilar Research & Development 2026.”
About Regenix Drugs Ltd
Founded with a mission to deliver affordable, high-quality, and globally trusted medicines, Regenix Drugs Ltd has rapidly ascended as a pioneering force in biosimilars, specialty drugs, and breakthrough therapies. With a robust R&D infrastructure, stringent quality standards, and a growing international footprint, Regenix embodies India’s stature as the Pharmacy of the World.Regenix Drugs Ltd (RDL), a public limited company incorporated in 2007 and headquartered in Chennai, Tamil Nadu, stands as a testament to the vision of dedicated healthcare professionals. With a strong foundation in science and integrity, RDL is engaged in the manufacturing and marketing of formulations, including both small molecules and biosimilar products, across India. Expanding its global footprint, RDL also exports its high-quality pharmaceutical products to CIS, African, and Asian markets, reinforcing its commitment to making advanced and affordable healthcare accessible worldwide.
- Core Strengths: Biosimilars, oncology, immunology, and life-saving generics.
- Global Reach: Expanding presence across regulated markets in the US, EU, and Asia.
- Commitment: Innovation-driven, patient-centric, and uncompromising on quality.
A visionary entrepreneur and scientist, Dr. A. Ramamurthy has dedicated his career to advancing biosimilar research and democratizing access to cutting-edge therapies. His leadership at Regenix Group has positioned the company as a trusted global partner in healthcare innovation.
- Leadership Style: Blends scientific rigor with entrepreneurial foresight.
- Impact: Driving India’s leadership in biosimilars, ensuring affordability without compromising quality.
- Recognition: Universally respected as a healthcare pioneer shaping the future of global medicine.
The 2026 summit convened India’s most influential healthcare pioneers, visionaries, and medical practitioners under the progressive theme: “Reimagining Healthcare – Powering Trust, Innovation & Global Impact.” The dual honors bestowed upon Regenix Drugs Ltd and Dr. Ramamurthy underscore their transformative role in shaping healthcare innovation, trust, and accessibility worldwide.
